Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q2 EPS of ($0.17), $0.15 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $1.57 million versus the consensus estimate of $5.6 million.

For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.